Bailey HH - Search Results

1

Phase I clinical trial of perillyl alcohol administered daily.

Ripple GH, Gould MN, Stewart JA, Tutsch KD, Arzoomanian RZ, Alberti D, Feierabend C, Pomplun M, Wilding G, Bailey HH. Ripple GH, et al. Among authors: bailey hh. Clin Cancer Res. 1998 May;4(5):1159-64. Clin Cancer Res. 1998. PMID: 9607573 Clinical Trial.

2

Increase in gamma-glutamylcysteine synthetase activity and steady-state messenger RNA levels in melphalan-resistant DU-145 human prostate carcinoma cells expressing elevated glutathione levels.

Bailey HH, Gipp JJ, Ripple M, Wilding G, Mulcahy RT. Bailey HH, et al. Cancer Res. 1992 Sep 15;52(18):5115-8. Cancer Res. 1992. PMID: 1355406

3

Human metabolism of the experimental cancer therapeutic agent d-limonene.

Crowell PL, Elson CE, Bailey HH, Elegbede A, Haag JD, Gould MN. Crowell PL, et al. Among authors: bailey hh. Cancer Chemother Pharmacol. 1994;35(1):31-7. doi: 10.1007/BF00686281. Cancer Chemother Pharmacol. 1994. PMID: 7987974

4

Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathione.

Bailey HH, Mulcahy RT, Tutsch KD, Arzoomanian RZ, Alberti D, Tombes MB, Wilding G, Pomplun M, Spriggs DR. Bailey HH, et al. J Clin Oncol. 1994 Jan;12(1):194-205. doi: 10.1200/JCO.1994.12.1.194. J Clin Oncol. 1994. PMID: 8270977 Clinical Trial.

5

Phase I study of continuous-infusion L-S,R-buthionine sulfoximine with intravenous melphalan.

Bailey HH, Ripple G, Tutsch KD, Arzoomanian RZ, Alberti D, Feierabend C, Mahvi D, Schink J, Pomplun M, Mulcahy RT, Wilding G. Bailey HH, et al. J Natl Cancer Inst. 1997 Dec 3;89(23):1789-96. doi: 10.1093/jnci/89.23.1789. J Natl Cancer Inst. 1997. PMID: 9392620 Clinical Trial.

6

Breast cancer.

Carbone PP, Bailey HH, Stewart JA. Carbone PP, et al. Among authors: bailey hh. Cancer Chemother Biol Response Modif. 1997;17:562-611. Cancer Chemother Biol Response Modif. 1997. PMID: 9551231 Review. No abstract available.

7

Paclitaxel, carboplatin, and hexamethyl-melamine (taxchex) as first-line therapy for ovarian cancer.

Hartenbach EM, Harris LS, Bailey HH, Grosen EA, Larrison E, Chen D, Twiggs LB, Schink JC. Hartenbach EM, et al. Among authors: bailey hh. Cancer J Sci Am. 1999 Nov-Dec;5(6):348-55. Cancer J Sci Am. 1999. PMID: 10606476

8

Phase I clinical and pharmacokinetic study of perillyl alcohol administered four times a day.

Ripple GH, Gould MN, Arzoomanian RZ, Alberti D, Feierabend C, Simon K, Binger K, Tutsch KD, Pomplun M, Wahamaki A, Marnocha R, Wilding G, Bailey HH. Ripple GH, et al. Among authors: bailey hh. Clin Cancer Res. 2000 Feb;6(2):390-6. Clin Cancer Res. 2000. PMID: 10690515 Clinical Trial.

9

A phase II trial of daily perillyl alcohol in patients with advanced ovarian cancer: Eastern Cooperative Oncology Group Study E2E96.

Bailey HH, Levy D, Harris LS, Schink JC, Foss F, Beatty P, Wadler S. Bailey HH, et al. Gynecol Oncol. 2002 Jun;85(3):464-8. doi: 10.1006/gyno.2002.6647. Gynecol Oncol. 2002. PMID: 12051875 Clinical Trial.

10

Phase I clinical and pharmacokinetic trial of the cyclin-dependent kinase inhibitor flavopiridol.

Thomas JP, Tutsch KD, Cleary JF, Bailey HH, Arzoomanian R, Alberti D, Simon K, Feierabend C, Binger K, Marnocha R, Dresen A, Wilding G. Thomas JP, et al. Among authors: bailey hh. Cancer Chemother Pharmacol. 2002 Dec;50(6):465-72. doi: 10.1007/s00280-002-0527-2. Epub 2002 Oct 2. Cancer Chemother Pharmacol. 2002. PMID: 12451473 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters